Business Context and Reporting Period
This Form 8-K is a current report filed by Avery Dennison Corporation on April 22, 2003. The filing primarily serves to disseminate the company's earnings results for the quarter ended March 29, 2003, which are detailed in the attached news release (Exhibit 99.1). Additionally, the report addresses a significant legal development involving a U.S. Department of Justice complaint filed on April 15, 2003, regarding a proposed merger between UPM-Kymmene, Oyj and Bemis Company, Inc., in which Avery Dennison is identified as the "Leading Producer."
Key Financial Metrics
The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These financial metrics are referenced as being contained within Exhibit 99.1 (the news release), which is attached to the filing but not included in the provided text. Consequently, no specific financial figures can be extracted from this document alone.
Material Changes and Legal Developments
- Earnings Announcement: The company announced its first-quarter 2003 financial results on April 22, 2003.
- DOJ Antitrust Action: The U.S. Department of Justice filed a complaint in the U.S. District Court for the Northeastern District of Illinois to prevent the merger of UPM-Kymmene and the MACtac division of Bemis Company, Inc.
- Company Involvement: Avery Dennison is explicitly named as the "Leading Producer" in the DOJ complaint, indicating its central role in the competitive practices under investigation in the label stock industry.
Guidance, Risks, and Contingencies
The filing includes a "Safe Harbor" statement regarding forward-looking statements, noting that actual results may differ due to various risks. Key risks and contingencies identified include:
- Legal Proceedings: The impact of the U.S. Department of Justice criminal investigation into competitive practices in the label stock industry and related proceedings.
- Economic Factors: Worldwide and local economic conditions, including the specific impact of Severe Acute Respiratory Syndrome (SARS) on the economy, customers, and business operations.
- Operational Risks: Price and availability of raw materials, foreign exchange rates, successful integration of acquired companies, and fluctuations in customer demand.
- Customer Factors: Financial condition and inventory strategies of customers.
The company states it undertakes no obligation to update these forward-looking statements to reflect subsequent events.
Investor Verification Checklist
- Review Exhibit 99.1 (the April 22, 2003 news release) to obtain specific Q1 2003 revenue, earnings, and cash flow figures.
- Examine Exhibit 99.2 to understand the full scope of the DOJ complaint and the specific allegations regarding the label stock industry.
- Assess the potential financial and operational impact of the DOJ investigation on Avery Dennison's future competitive position and legal liabilities.
- Monitor the economic impact of SARS on the company's customer base and supply chain as highlighted in the risk factors.
- Verify the status of the UPM-Kymmene and Bemis merger proceedings and any subsequent regulatory actions.